Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial. [electronic resource]
- Archives internationales de pharmacodynamie et de therapie Dec 1980
- 251-9 p. digital
Arrhythmias, Cardiac--drug therapy Clinical Trials as Topic Disopyramide--adverse effects Electrocardiography Humans Lidocaine--therapeutic use Mexiletine--adverse effects Propylamines--therapeutic use Pyridines--therapeutic use Random Allocation